CIAM
VYGR icon

Caitong International Asset Management’s Voyager Therapeutics VYGR Stock Holding History

Caitong International Asset Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9K Buy
3,978
+3,841
+2,804% +$14.6K ﹤0.01% 1074
2026
Q1 		$529 Sell
137
-15,592
-99% -$61.4K ﹤0.01% 1628
2025
Q4 		$61.8K Buy
15,729
+15,692
+42,411% +$69.4K 0.02% 624
2025
Q3 		$173 Buy
+37
New +$134 ﹤0.01% 1686
2025
Q2 		– Sell
-445
Closed -$1.5K – 2535
2025
Q1 		$1.5K Buy
+445
New +$2.08K ﹤0.01% 1447

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Caitong International Asset Management's VYGR Position: Q2 2026 in Review

Caitong International Asset Management increased its Voyager Therapeutics (VYGR) stake by 2,804% in Q2 2026, buying an estimated $14.6K and bringing the position to 3,978 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1074.

Caitong International Asset Management first reported a position in VYGR in Q1 2025 and has held it in 5 quarters since. The position peaked at $61.8K in Q4 2025. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Caitong International Asset Management held 3,978 shares of Voyager Therapeutics worth $13.9K as of Q2 2026.
  • Caitong International Asset Management bought 3,841 Voyager Therapeutics shares in Q2 2026, an estimated $14.6K.
  • Voyager Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1074 holding.
  • Caitong International Asset Management first reported a position in Voyager Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Voyager Therapeutics position peaked at $61.8K in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.